← Back to headlines
Candel Therapeutics Prices $100 Million Public Offering
Candel Therapeutics has priced a public offering aiming to raise $100 million.
20 Feb, 13:40 — 20 Feb, 13:40
Sources
Showing 1 of 1 sources
Candel Therapeutics has priced a public offering aiming to raise $100 million.
